Q fever in pregnancy: A case report and review of the literature;Q-fieber in der schwangerschaft: Therapie und handling des krankheitsbildes anhand eines fallberichtes

Zeitschrift fur Geburtshilfe und Neonatologie

Volumn 206, Issue 5, 2002, Pages 193-198

  Hellmeyer, Lars ^a   Schmitz Ziegler, G ^a   Slenczka, W ^b   Schmidt, S ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b Institut fur Virologie   (Germany)

Author keywords

Pregnancy; Prenatal diagnosis; Q fever; Rifampicin

Indexed keywords

CLARITHROMYCIN; COTRIMOXAZOLE; RIFAMPICIN;

ACUTE DISEASE; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COXIELLA BURNETII; ENDEMIC DISEASE; GERMANY; HUMAN; MASS SCREENING; POPULATION RESEARCH; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PREVALENCE; Q FEVER; SEROCONVERSION; SERODIAGNOSIS; SPONTANEOUS ABORTION; VIRUS PNEUMONIA;

ADULT; ANTIBODIES, BACTERIAL; CHRONIC DISEASE; CLARITHROMYCIN; COXIELLA BURNETII; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MASS SCREENING; OBSTETRIC LABOR, PREMATURE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; Q FEVER; RIFAMPIN; TREATMENT OUTCOME;

EID: 0036760064     PISSN: 09482393     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34961     Document Type: Article

References (34)

1. Maurin M, Raoult D. In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetii to clarithromycin. Antimicrob Agents Chemother 1993; 37: 2633-2637
2. Gikas A, Spyridaki I, Scoulica E, Psaroulaki A, Tselentis Y. In vitro susceptibility of Coxiella burnetii to Linezolid in comparison with its susceptibilities to Quinolones, Doxycycline, and Clarithromycin. Antimicrob Agents Chemother 2001; 45: 3276-3278
3. Raoult D, Torres H, Drancourt M. Shell-vial assay: Evaluation of a new Technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii. Antimicrob Agents Chemother 1991; 35: 2070-2077
4. Raoult D, Drancourt M, Vestris G. Bactericidal effect of Doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells. Antimicrob Agents Chemother 1990; 34: 1512-1514
5. Yeaman MR, Mitscher LA, Baca OG. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob Agents Chemother 1987; 31: 1079-1084
6. Maurin M, Raoult D. Q fever. Clin Microbiol Reviews 1999; 12: 518-553
7. Raoult D, Stein A. Q fever during pregnancy, a risk for woman, foetuses and obstetricians. N Engl J Med 1994; 330: 371
8. Bental T, Fejgin M, Keysary A, Rzotkiewicz S, Oron C, Nachum R, Beyth Y, Lang R. Chronic Q fever of pregnancy presenting as Coxiella burnetii placentitis: Successful outcome following therapy with erythromycin and rifampicin. Clin Infect Dis 1995; 21: 1318-1321
9. Bekanntmachungen des Bundesgesundheitsamtes. Bundesgesundhbl. Sonderheft/94 : 35-36
10. Srigley JR, Vellend H, Palmer N, Phillips MJ, Geddie WR, Van Nostrand AW, Edwards VD. Q-fever. The liver and bone marrow pathology. Am J Surg Pathol 1985; 9: 752-758
11. Robert Koch-Institut. Epidemiologisches Bulletin, 33/99
12. Meiklejohn G, Reimer LG, Graves PS, Helmick C. Cryptic epidemic Q Fever in a medical school. J Infect Dis 1981; 144: 107-112
13. Hall CJ, Richmond SJ, Caul EO, Pearce NH, Silver IA. Laboratory outbreak of Q Fever acquired from sheep. Lancet 1982; 1: 1004-1006
14. Pinsky RL, Fishbein DB; Greene CR, Gensheimer KF. An outbreak of catassociated Q Fever In the United States. J Infect Dis 1991; 164: 202-204
15. Stein A, Raoult D. Pigeon pneumonia in provence: A bird-borne Q fever outbreak. Clin Infect Dis 1999; 29: 617-620
16. Lyytikäinen O, Ziese T, Schwartländer B, Matzdorff C, Kuhnhen C, Jäger C, Petersen L. An outbreak of sheep-associated Q fever in a rural community in Germany. Eur J Epidemiol 1998; 14: 193-199
17. Robert Koch-Institut. Epidemiologisches Bulletin, 4/97
18. Robert Koch-Institut. Epidemiologisches Bulletin, 36/97
19. Norlander L. Q fever epidemiology and pathogenesis. Microbes and Infection 2000; 2: 417-424
20. Raoult D, Tissot-Dupont H, Foucault C, Gouvernet J, Fournier PE, Bernit E, Stein A, Nesri M, Harle Jr, Waller PJ. Q Fever 1985-1998: Clinical and epidemiology features of 1383 infections. Medicine (Baltimore) 2000; 79: 109-123
21. Raoult D, Fenollar F, Stein A. Q fever during pregnancy. Arch Intern Med 2002; 162: 701-704
22. Rey D, Obadia Y, Tissot-Dupont H, Raoult D. Seroprevalence of antibodies to Coxiella burnetii among pregnant women in South Eastern France. Eur J Obstet Gynecol Reprod Biol 2000; 93: 151-156
23. Numazaki K, Ueno H, Yokoo K, Muramatsu Y, Chiba S, Morita C. Detection of serum antibodies to Bartonella henselae and Coxiella burnetii from Japanese children and pregnant woman. Microbes Infect 2000; 2: 1431-1434
24. Anstey NM, Tissot-Dupont H, Hahn CG, Mwaikamlo ED, Mc Donald M, Raoult D, Sexton DJ. Seroepidemiology of Rickettsia typhi spotted fever group, rickettsiae and Coxiella buretii infection in pregnant from urban Tanzania. Am J Trop Med Hyg 1997; 57: 187-189
25. Stein A, Raoult D. Q Fever during pregnancy: A public health problem in Southern France. Clin Infect Dis 1998; 27: 592-596
26. Stein A, Lepidi H, Mege JL, Marrie TJ, Raoult D. Repeates pregnancies in BALB/c mice infected with Coxiella burnetii cause disseminated infection, resulting in stillbirth and Endokarditis. J Infect Dis 2000; 181: 188-194
27. Ludlam H, Wreghitt TG, Thornton S, Thomson BJ, Blahop NJ, Coomber S, Cunnilfe J. Q Fever in pregnancy. J Infect 1997; 34: 75-78
28. Jover-Diaz F, Robert-Gates J, Andreu-Gimenez L, Merino-Sanchez J. Q fever during pregnancy: An emerging cause of prematurity and abortion. Infect Dis Obstet Gynecol 2001; 9: 47-49
29. Fachinformation Klacid®. Abbott GmbH, März 1993
30. Raoult D. Antibiotic susceptibility of rickettsia and treatment of rickettsioses. Eur J Epidemiol 1989; 5: 432-435
31. Raoult D, Houplkian P, Tissot Dupont H, Riss JM, Arditi-Djiane J, Brouqui P. Comparison of 2 regimens containing doxycycline and ofloxacin or hydrochloroquine. Arch Intern Med 1999; 159: 167-173
32. Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D. Risk factors and prevention of Q-fever Endokarditis. Clin Infect Dis 2001; 33: 312-316
33. Robert Koch-Institut. Epidemiologisches Bulletin, 22/97
34. Robert Koch-Institut. Epidemiologisches Bulletin, 49/97